Pressure BioSciences Inc. PBIO Archives - Page 9 of 22

FridayJun 19, 2020 1:58 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Pending Acquisition Target Secures $3.5M Initial Hand Sanitizer Order

Pressure BioSciences (OTCQB: PBIO), recently announced that SkinScience Labs (“SSL”) has secured an initial $3.5 million order for its premium FDA-registered dermatological hand sanitizer product (http://ibn.fm/KE7x5). A leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions, Pressure BioSciences will acquire SSL through its planned acquisition of Cannaworx, which is expected to close by June 30, 2020. A recent article discussing the company further reads, “The $3.5 million order announced on June 11 is merely the initial order for a four-month supply of the premium, dermatological, hand-sanitizer product. Mr. Morrison expects future orders and…

ThursdayJun 18, 2020 11:01 am

Pressure BioSciences, Inc. (PBIO) Enters Multi-Billion Dollar Hand Sanitizer Market Following $3.5M Initial Order for Pending Acquisition Partner SkinScience Labs’ Premium New Product

Merger of Pressure BioSciences, SkinScience Labs and Cannaworx, Inc. is expected to close by June 30, 2020 SkinScience Labs is the parent company of the award-winning Dr. Denese skin care and anti-aging product lines, a top QVC seller generating sales of over $500M since 2003 The $3.5M order is for an initial four-month supply of SkinScience Labs’ (SSL)premium grade hand sanitizer Hand sanitizer market is growing exponentially; it is expected to reach $5.5 billion by 2024 SkinScience Labs and Cannaworx product lines will leverage Pressure BioSciences’ proprietary Ultra Shear Technology (UST) for preparing high quality nanoemulsions to drive product quality…

ThursdayJun 11, 2020 11:13 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Merger Partner, SkinScience Labs, Secures Initial $3.3M Order for Premium Hand Sanitizer Product

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its merger partner SkinScience Labs, Inc. has received an initial $3.5 million order for its newly developed, premium, dermatological hand sanitizer product. An industry leader in scientific skin care breakthrough technologies, Adrienne Denese, M.D., Ph.D. (Cornell, Harvard) is the founder of the award-winning Dr. Denese SkinScience® product lines. "Our goal has always been to develop and supply the highest quality of personal care products…

ThursdayJun 04, 2020 11:43 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Initial Manufacturing Run of Revolutionary BaroShear(TM) K45 Processing System Completely Sold Out

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its receipt of an order for the 12th and final system scheduled to be built in the Company's initial manufacturing run of its revolutionary BaroShear(TM) K45 processing system. The BaroShear K45, based on the Company's proprietary Ultra Shear Technology(TM) (UST(TM)) platform, is a unique and powerful nanoemulsification system designed to resolve one of today’s most critical problems facing the global hemp-derived cannabinoid industry: how to…

ThursdayMay 28, 2020 12:51 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Pending Partner Cannaworx to Launch FDA Registered, Hemp-Containing Supplements with Immune Booster Claim

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its pending merger partner Cannaworx, Inc. will be launching its patented and proprietary immune booster supplement by mid-July 2020. According to the update, the company believes that post-launch, this product could be one of the very few, and perhaps the only, OTC (over the counter), FDA registered, hemp-containing supplements with an immune booster claim. “To further enhance the immune boosting effect, we added hemp…

WednesdayMay 27, 2020 2:52 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Targets Massive International Markets

Pressure BioScience (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries. On April 29, PBIO announced its entrance into a binding letter of intent to acquire Cannaworx Inc. (http://ibn.fm/TfZgu). An article discussing the company reads, “The merged entity, equipped with an extensive intellectual property portfolio utilizing a proprietary pressure platform, nanotechnology and advanced delivery systems, plans to disrupt a number of major world markets. These include the international cosmetics market, projected to reach $758 billion by 2025…

WednesdayMay 20, 2020 9:26 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Pending Merger Partner Enters LOI to Acquire Five Leaf Labs

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, on Tuesday announced that one of its two pending merger partners, Cannaworx, Inc., is substantially expanding its sales and distribution network through a letter of intent (“LOI”) to acquire Louisiana-based Five Leaf Labs (“FLL”). FLL recently released its first set of CBD-infused products to the U.S. market. “We attribute the success of our initial launch to both the high quality of our hemp source supply and processing…

ThursdayMay 14, 2020 10:03 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Premium Hand Sanitizer as First Product to be Released Under New Holding Company

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that, following its pending merger and name change to Availa Bio, the newly branded, publicly-traded company will be entering the hand sanitizer market through the founders of Cannaworx. According to the update, the custom-designed, premium hand sanitizer will be the first product released under the new holding company Availa Bio. Owners of the privately held Cannaworx, Inc. have obtained FDA registration for the newly developed…

ThursdayMay 07, 2020 12:05 pm

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Appointment of Personal Care Industry Leader as CEO to Lead Rebranded Company

Pressure BioScience (OTCQB: PBIO) today announced the appointment of personal care industry leader Jim Morrison to serve as the new CEO of the rebranded public company, with intended corporation name of Availa Bio, upon completion of the merger with Cannaworx, SkinScience Labs and Pressure BioSciences. Morrison’s career includes numerous leadership positions in the personal care industry, most notably as President of L'Oréal where he oversaw growth that averaged more than 20% year-over-year. In addition, Morrison engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth. “Jim is one of the preeminent beauty and…

WednesdayMay 06, 2020 12:21 pm

Pressure BioSciences Inc. (PBIO) and Cannaworx Inc. Announce Merger Targeting Markets with Massive Cumulative Value

The merged company will target the international cosmetics market (projected to reach $758 billion by 2025), agricultural technology and products ($729 billion by 2023), the biopharmaceuticals market ($389 billion by 2024) and the hemp-derived CBD market ($23.7 billion by 2023) Cannaworx has a diverse portfolio and plans to launch several products in 2020, including two with a pain indication allowed under an FDA OTC monograph Cannaworx’s sativa oil skincare serum sold $250K in 10 minutes on QVC in December 2019 Merger will give Cannaworx access to Pressure BioSciences’ proprietary method for processing oil-based products into high quality nanoemulsions (Ultra shear Technology), which…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO